State of the Art: Concise ReviewPD-L1 Expression in Lung Cancer
Under an Elsevier user license
open archive
Keywords
Lung cancer
Biomarker
PD-L1
Immunotherapy
Cited by (0)
Drs. Yu and Boyle contributed equally to this article.
Disclosure: Dr. Boyle an honorarium from Bristol-Meyers Squibb outside the submitted work. Dr. Rimm reports grants from Genoptix and Gilead Sciences during conduct of the study and personal fees from Bristol-Meyer Squibb and AstraZeneca outside the submitted work. The remaining authors declare no conflict of interest.
© 2016 International Association for the Study of Lung Cancer. Published by Elsevier Inc.